114 related articles for article (PubMed ID: 2717189)
1. [Resistance of staphylococci to intracellular killing by macrophages--a new pathophysiologic concept of acute hematogenous osteomyelitis in childhood and its therapeutic consequences].
Guggenbichler JP; Bonatti H; Rottensteiner F
Padiatr Padol; 1989; 24(1):21-32. PubMed ID: 2717189
[TBL] [Abstract][Full Text] [Related]
2. [Infections of the cerebrospinal fluid shunt].
Menardi G
Padiatr Padol; 1989; 24(1):43-8. PubMed ID: 2717191
[TBL] [Abstract][Full Text] [Related]
3. [The effect of clindamycin on intraphagocytic Staphylococcus aureus in leukocytes from patients with chronic osteomyelitis].
Burgaleta C; Velasco GL; Peletier R; Messeguer M; Pernas M
Enferm Infecc Microbiol Clin; 1992 Mar; 10(3):143-7. PubMed ID: 1576187
[TBL] [Abstract][Full Text] [Related]
4. Tolerant Staphylococcus aureus causing vertebral osteomyelitis.
Musher DM; Fletcher T
Arch Intern Med; 1982 Mar; 142(3):632-4. PubMed ID: 6917742
[TBL] [Abstract][Full Text] [Related]
5. [Cotrimoxazole plus rifampicin in the treatment of staphylococcal osteoarticular infection].
Sánchez C; Matamala A; Salavert M; Cuchí E; Pons M; Anglés F; Garau J
Enferm Infecc Microbiol Clin; 1997 Jan; 15(1):10-3. PubMed ID: 9147500
[TBL] [Abstract][Full Text] [Related]
6. Clindamycin treatment of osteomyelitis and septic arthritis in children.
Feigin RD; Pickering LK; Anderson D; Keeney RE; Shackleford PG
Pediatrics; 1975 Feb; 55(2):213-23. PubMed ID: 1118208
[TBL] [Abstract][Full Text] [Related]
7. Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children.
Martínez-Aguilar G; Hammerman WA; Mason EO; Kaplan SL
Pediatr Infect Dis J; 2003 Jul; 22(7):593-8. PubMed ID: 12867833
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of clindamycin in the treatment of Staphylococcus aureus osteomyelitis in dogs.
Braden TD; Johnson CA; Wakenell P; Tvedten HW; Mostosky UV
J Am Vet Med Assoc; 1988 Jun; 192(12):1721-5. PubMed ID: 3410788
[TBL] [Abstract][Full Text] [Related]
9. Protection of Staphylococcus aureus-infected septic mice by suppression of early acute inflammation and enhanced antimicrobial activity by ginsan.
Ahn JY; Song JY; Yun YS; Jeong G; Choi IS
FEMS Immunol Med Microbiol; 2006 Mar; 46(2):187-97. PubMed ID: 16487300
[TBL] [Abstract][Full Text] [Related]
10. Comparison of fosfomycin and teicoplanin in serum bactericidal activity against staphylococci.
Vogt K; Rauhut A; Trautmann M; Hahn H
Arzneimittelforschung; 1995 Aug; 45(8):894-7. PubMed ID: 7575756
[TBL] [Abstract][Full Text] [Related]
11. Phagocytosis and killing of cefazolin-exposed Staphylococci and Bacilli by mouse peritoneal macrophages.
Carlone NA; Cuffini AM; Cattaneo O; Cavallo G
Int J Tissue React; 1982; 4(1):31-40. PubMed ID: 6806177
[TBL] [Abstract][Full Text] [Related]
12. Combination chemotherapy for infections due to methicillin-resistant Staphylococcus aureus with combination therapy by cefuzonam and fosfomycin or minocycline in the urologic field.
Matsumoto T; Kubo S; Haraoka M; Takahashi K; Tanaka M; Sakumoto M; Kumazawa J
Clin Ther; 1993; 15(5):819-28. PubMed ID: 8269448
[TBL] [Abstract][Full Text] [Related]
13. What would pediatric infectious disease consultants recommend for management of culture-negative acute hematogenous osteomyelitis?
Afghani B; Kong V; Wu FL
J Pediatr Orthop; 2007; 27(7):805-9. PubMed ID: 17878789
[TBL] [Abstract][Full Text] [Related]
14. Oral step-down therapy is comparable to intravenous therapy for Staphylococcus aureus osteomyelitis.
Daver NG; Shelburne SA; Atmar RL; Giordano TP; Stager CE; Reitman CA; White AC
J Infect; 2007 Jun; 54(6):539-44. PubMed ID: 17198732
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutic effect of some antibiotics on experimental staphylococcal infection and its correlation with in vitro activity of antibiotics in sub-inhibitory concentration against Staphylococcus aureus strains].
Kaczmarska L; Jakoniuk P
Med Dosw Mikrobiol; 2003; 55(1):1-10. PubMed ID: 12908409
[TBL] [Abstract][Full Text] [Related]
16. [Are we being threatened by multiresistant strains of Staphylococcus aureus?].
Aepfelbacher M
MMW Fortschr Med; 2005 Jan; 147(4):33-5, 37. PubMed ID: 15745339
[TBL] [Abstract][Full Text] [Related]
17. Treatment of experimental osteomyelitis by liposomal antibiotics.
Kadry AA; Al-Suwayeh SA; Abd-Allah AR; Bayomi MA
J Antimicrob Chemother; 2004 Dec; 54(6):1103-8. PubMed ID: 15486079
[TBL] [Abstract][Full Text] [Related]
18. Microbiological indications for the treatment of Staphylococcus aureus infections.
Fabbri A; Tacchella A; Belli ML; Losurdo G
Chemioterapia; 1988 Dec; 7(6):378-81. PubMed ID: 3219748
[TBL] [Abstract][Full Text] [Related]
19. [The rate of inducible clindamycin resistance and susceptibilities to other antimicrobial agents in staphylococci].
Oğuz VA; Yapar N; Sezak N; Cavuş SA; Kurutepe S; Peksel H; Cakir N; Yüce A
Mikrobiyol Bul; 2009 Jan; 43(1):37-44. PubMed ID: 19334378
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of osteomyelitis with oral bactericidal antibiotics-- description of 9 cases].
Major S; Chuard C; Regamey C
Schweiz Med Wochenschr; 1996 Jan; 126(4):124-7. PubMed ID: 8578294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
